Yeah, seems a bit low. I'm pretty sure someone made a post explaining how Azer-Cel alone would be worth about $US12b in a buyout scenario if approved to treat a limited number of blood cancer indications. Add in all the solid tumour targets provided by onCARlytics, plus onCARlytics itself and Vaxinia to potentially treat all solid tumours... I'll leave it for others to do the calculations but I'm sure it's a number higher than $US12b let alone AU$12b.
Yeah, seems a bit low. I'm pretty sure someone made a post...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.002(3.92%) |
Mkt cap ! $387.9M | |||
| Open | High | Low | Value | Volume |
| 5.1¢ | 5.3¢ | 5.0¢ | $605.4K | 11.73M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 455000 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 1913821 | 7 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |